BEVACIZUMAB, Avastin 25 mg/ml concentrate for solution for infusion., BEVACIZUMAB clinical trials

An open label, Phase IV study to assess immunological changes in patients with glioblastoma multiforme treated with bevacizumab infusion

This study is looking at how a treatment called bevacizumab (also known as Avastin) affects the body's defence system in people with a type of brain tumour called glioblastoma multiforme. The aim is to understand more about the disease and how well patients respond to treatment.